WELCOME TO SERVIER CENTRAL AMERICA AND THE CARIBBEAN
WEBSITE

More information about the Servier group

21800

employees

150

countries in which the Group’s
medicines are distributed

+20%

20% of the brand-name
revenue in R&D every year

€4.7 billion

euros in revenue in 2020/2021 comprising €3.3
billion for brand-name medicines and €1.4 billion
for generic medicines

4 therapeutic areas

Oncology, Neuroscience, Immuno-
inflammation, Cardiometabolism

OUR COMMITMENTS

At Servier, we believe that providing future generations with a healthier world is at the heart of our mission. As a leading pharmaceutical company, we work towards our purpose with passion, dedication and determination. This conviction is embodied first and foremost in the central place we give to the patient, but also in our ethics and compliance standards, and in our corporate social responsibility policy.